Anuh Pharma Limited (BOM:506260)

Anuh Pharma Balance Sheet

Financials in millions INR. Fiscal year is April - March.

Assets

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Cash & Equivalents	80.6	195.57	72.02	19.27	37.96
Short-Term Investments	59.52	15.02	12.37	8.1	-
Trading Asset Securities	389.08	523.56	538.17	503.4	214.69
Cash & Short-Term Investments	529.19	734.15	622.56	530.77	252.65
Cash Growth	-27.92%	17.92%	17.29%	110.08%	91.21%
Accounts Receivable	2,386	2,159	1,899	1,712	1,357
Other Receivables	87.72	97.33	61.96	39.14	5.25
Receivables	2,482	2,261	1,968	1,756	1,370
Inventory	1,478	744.81	754	726.36	799.23
Prepaid Expenses	16.8	17.72	5.88	5.72	4.79
Restricted Cash	-	-	-	30.5	-
Other Current Assets	7.3	3.54	35.29	26.61	159.98
Total Current Assets	4,513	3,762	3,385	3,076	2,587
Property, Plant & Equipment	560.92	583.66	492.42	526.76	613.41
Long-Term Investments	395.83	619.55	517.14	396.84	212.13
Other Intangible Assets	5.29	1.21	1.58	1.31	1.83
Long-Term Deferred Tax Assets	38.62	20.8	4.22	7.68	-
Other Long-Term Assets	58.97	77.76	53.99	41.09	57.51
Total Assets	5,574	5,066	4,457	4,050	3,472

Liabilities

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Accounts Payable	1,877	1,568	1,405	1,528	1,216
Accrued Expenses	6.96	7.08	6.16	4.74	3.34
Short-Term Debt	-	104.98	20.13	-	31.11
Current Portion of Leases	0.58	3.3	2.91	0.67	2.06
Current Income Taxes Payable	23.16	5.48	-	-	-
Other Current Liabilities	122.75	95.85	92.72	80.29	56.81
Total Current Liabilities	2,030	1,785	1,527	1,613	1,309
Long-Term Leases	-	0.58	3.88	8.39	9.07
Pension & Post-Retirement Benefits	12.21	12.92	11.05	9.91	9.72
Long-Term Deferred Tax Liabilities	-	-	-	-	0.48
Other Long-Term Liabilities	9.21	7.39	2.75	5.93	5.69
Total Liabilities	2,051	1,806	1,545	1,638	1,334

Shareholders' Equity

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Common Stock	501.12	250.56	250.56	250.56	250.56
Retained Earnings	3,018	3,009	2,660	2,160	1,886
Comprehensive Income & Other	2.99	1.14	1.31	1.69	1.3
Shareholders' Equity	3,522	3,260	2,912	2,412	2,138
Total Liabilities & Equity	5,574	5,066	4,457	4,050	3,472

Additional Metrics

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Total Debt	0.58	108.86	26.93	9.07	42.24
Net Cash (Debt)	528.61	625.28	595.63	521.7	210.41
Net Cash Growth	-15.46%	4.98%	14.17%	147.94%	-
Net Cash Per Share	5.27	12.48	5.94	5.21	2.10
Filing Date Shares Outstanding	100.22	100.22	100.22	100.22	100.22
Total Common Shares Outstanding	100.22	100.22	100.22	100.22	100.22
Working Capital	2,483	1,977	1,858	1,463	1,278
Book Value Per Share	35.14	32.53	29.06	24.07	21.33
Tangible Book Value	3,517	3,259	2,911	2,411	2,136
Tangible Book Value Per Share	35.09	32.52	29.04	24.06	21.31
Land	15.59	15.59	15.59	113.07	113.07
Buildings	148.57	146.73	146.73	146.73	146.73
Machinery	1,032	941.3	767.32	723.6	713.5
Construction In Progress	-	2.72	4.54	-	1

Data Source: S&P Global Market Intelligence Last updated: Mar 31, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Jul 23, 2026

Data Sources Report a data error